FluoGuide A/S takes next step
2025-01-20
At LSIF we are pleased to see that FluoGuide A/S has now recieved approval for the phase II trial in head and neck cancer taking the next step for FG001. Enrollment of the needed 25 - 30 patients starts this quarter and interrim data is expected in H2 2025. It will be interesting to hopefully soon get news regarding partners for Fluoguide going forward.
